These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 2976341)

  • 1. [Severe proarrhythmic effects of flecainide].
    Frabetti F; Dattola L; Bellodi G; Padovani F
    Clin Ter; 1988 Oct; 127(1):43-7. PubMed ID: 2976341
    [No Abstract]   [Full Text] [Related]  

  • 2. [QT prolongation and induction of torsades de pointe by flecainide. Apropos of a case].
    Wickers F; Haissaguere M; Palussiere J
    Arch Mal Coeur Vaiss; 1988 Oct; 81(10):1283-5. PubMed ID: 3146965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anomalies of the T waves induced by flecainide].
    Stoltz JP; Weingrod M; Leroy G; Halphen C; Haïat R
    Arch Mal Coeur Vaiss; 1988 Aug; 81(8):1009-12. PubMed ID: 3144249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flecainide acetate: critical care administration guidelines.
    Senior S; Baessler C; Monzo M
    Heart Lung; 1988 Jan; 17(1):76-80. PubMed ID: 3123423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Worsening of ventricular arrhythmia in the dynamic ECG in patients treated with anti-arrhythmia drugs].
    Lanza GA; Tamburi S; Mondello Malvestiti FM; Rebuzzi AG; Lucente M
    Cardiologia; 1988 Jun; 33(6):613-8. PubMed ID: 3139292
    [No Abstract]   [Full Text] [Related]  

  • 6. ECG diagnosis: flecainide toxicity.
    Levis JT
    Perm J; 2012; 16(4):53. PubMed ID: 23251119
    [No Abstract]   [Full Text] [Related]  

  • 7. Proarrhythmic effects of class Ic drugs.
    Moroe K; Annoura M; Matsuo K; Yamanouchi Y; Kumagai K; Arakawa K
    Clin Ther; 1993; 15(3):559-66. PubMed ID: 8364947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Encainide hydrochloride and flecainide acetate: two class 1c antiarrhythmic agents.
    Chase SL; Sloskey GE
    Clin Pharm; 1987 Nov; 6(11):839-50. PubMed ID: 3119276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent electrocardiographic changes after flecainide overdose.
    Greig J; Groden BM
    Br J Clin Pract; 1995; 49(4):218-9. PubMed ID: 7547168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proarrhythmic actions of flecainide in an isolated tissue model of ischemia and reperfusion.
    Heisler BE; Ferrier GR
    J Pharmacol Exp Ther; 1996 Oct; 279(1):317-24. PubMed ID: 8859009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use- and concentration-dependent effects of flecainide in guinea pig right ventricular muscle.
    Rouet R; Ducouret P
    J Cardiovasc Pharmacol; 1994 Aug; 24(2):177-83. PubMed ID: 7526048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flecainide acetate: concentration-response relationships for antiarrhythmic and electrocardiographic effects.
    Boriani G; Capucci A; Strocchi E; Calliva R; Santarelli A; Biffi M; Magnani B
    Int J Clin Pharmacol Res; 1993; 13(4):211-9. PubMed ID: 8150547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flecainide-induced neuropathy.
    Malesker MA; Sojka SG; Fagan NL
    Ann Pharmacother; 2005 Sep; 39(9):1580. PubMed ID: 16076915
    [No Abstract]   [Full Text] [Related]  

  • 14. [Be careful in using flecainide by hemodialyzed patients].
    Montagnac R; Schoen E; Aliouche CP; Schillinger F
    Nephrol Ther; 2006 Dec; 2(7):442-5. PubMed ID: 17185235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Torsade-de-pointes in a patient under flecainide treatment, an unusual case of proarrhythmicity.
    Nogales Asensio JM; Moreno Sánchez N; Doncel Vecino LJ; Villar Mariscal C; López-Mínguez JR; Merchán Herrera A
    Int J Cardiol; 2007 Jan; 114(2):E65-7. PubMed ID: 17056139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Oral flecainide in the treatment of refractory arrhythmias. Long-term follow-up of 98 patients].
    Haissaguerre M; Warin JF; Benchimol D; Le Métayer P; Regaudie JJ; Blanchot P
    Arch Mal Coeur Vaiss; 1987 Mar; 80(3):357-63. PubMed ID: 3113358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of serum flecainide trough levels in patients with tachyarrhythmia.
    Homma M; Kuga K; Doki K; Katori K; Yamaguchi I; Sugibayashi K; Kohda Y
    J Pharm Pharmacol; 2005 Jan; 57(1):47-51. PubMed ID: 15638992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Flecainide: a new antiarrhythmic agent].
    Leclercq JF; Coumel P
    Arch Mal Coeur Vaiss; 1983 Oct; 76(10):1218-30. PubMed ID: 6418100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of flecainide in the therapy of chronic ventricular arrhythmia using the acute oral load method].
    Schwartz PJ; Facchini M; Bonazzi O; Cuspidi C; Priori S; Varisco T; Zuanetti G
    G Ital Cardiol; 1985 Mar; 15(3):273-82. PubMed ID: 4018465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Propafenone and flecainide in the therapy of ventricular arrhythmias].
    Paperini L; Davini A; Lattanzi F; Topi A; Reisenhofer B; Squarcini G; Paci A; Topi PL
    Minerva Cardioangiol; 1995 Oct; 43(10):449-57. PubMed ID: 8819814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.